Using 3D wearable technology to predict breast cancer treatment outcomes
3D wearable NIR spectral tomography for early prediction of breast cancer’s residual cancer burden after neoadjuvant chemotherapy
['FUNDING_R01'] · DARTMOUTH COLLEGE · NIH-10939474
This study is testing a new, easy-to-use imaging method that helps doctors see how well chemotherapy is working for breast cancer patients, so they can better understand how much cancer is left after treatment and improve chances for a healthier future.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DARTMOUTH COLLEGE (nih funded) |
| Locations | 1 site (HANOVER, UNITED STATES) |
| Trial ID | NIH-10939474 on ClinicalTrials.gov |
What this research studies
This research investigates a new method using near-infrared spectral tomography (NIRST) to predict how much cancer remains in breast cancer patients after they undergo neoadjuvant chemotherapy. The approach is noninvasive, portable, and cost-effective, allowing for quick assessments of tumor response without the need for radiation or contrast agents. By capturing subtle changes in breast tissue, this technology aims to provide early insights into treatment effectiveness, potentially improving long-term survival rates for patients. The study will involve monitoring patients during their treatment to correlate imaging results with clinical outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with breast cancer who are about to begin neoadjuvant chemotherapy.
Not a fit: Patients who have already completed their chemotherapy or those with advanced metastatic breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate predictions of treatment effectiveness, ultimately improving survival outcomes for breast cancer patients.
How similar studies have performed: Previous studies have shown promising results with NIRST technology in monitoring tumor responses, indicating potential for success in this novel application.
Where this research is happening
HANOVER, UNITED STATES
- DARTMOUTH COLLEGE — HANOVER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JIANG, SHUDONG — DARTMOUTH COLLEGE
- Study coordinator: JIANG, SHUDONG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.